Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX)

CUSIP: 36246K103

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Shares, $0.001 par value
Total 13F shares
5,930,184
Total 13F value
$57,107,661
Holder snapshot 6 signals
Share change
+92,104
SEC-reported price per share
$9.63
Number of holders
53
Value change
+$937,653
Number of buys
19
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
15,447,782

Security key

36246K103

Report period

Q4 2025

Institutions

53

Top holders

10

GRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Gabelli Healthcare & WellnessRx Trust SEC filings

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GAMCO INVESTORS, INC. ET AL
Disclosed value leader
Saba Capital Management, ...
Comparable rows
15/15
Latest evidence
16 Dec 2025
13F 13D/G 3/4/5 Lead comparable stake: 34% 13D/G row: GAMCO INVESTORS, INC. ET AL Showing 1-6 of 15 holder rows.

Quick read

GAMCO INVESTORS, INC. ET AL leads the comparable SEC ownership view at 34%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GAMCO INVESTORS, INC. ET AL's linked filing trail.
Comparable ownership Top 5
GAMCO INVESTORS, INC. ET AL 34%
Saba Capital Management, L.P. 13%
SIT INVESTMENT ASSOCIATES INC 5.4%
Anthonie C. Vanekris 0.01%
WELLS FARGO & COMPANY/MN 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GAMCO INVESTORS, INC. ET AL
13F 13D/G
Company · Associated Capital Group, Inc.
13F 13D/G
34%
from 13D/G
$2,831,888
312,226 shares
 — 30 Sep 2025
Saba Capital Management, L.P.
3/4/5 13D/G 13F
10%+ Owner · Company
3/4/5 13D/G 13F
13%
from 13D/G
$19,826,361
2,118,201 shares
 +$1,047,244 16 Dec 2025
SIT INVESTMENT ASSOCIATES INC
13D/G 13F
Company
13D/G 13F
5.4%
$7,912,344
833,756 shares
 $0 30 Sep 2025
Anthonie C. Vanekris
3/4/5
Director
3/4/5
0.01%
$19,931
2,185 shares
 -$82,946 06 Aug 2025
WELLS FARGO & COMPANY/MN
13F
Company
13F
2.4%
$3,352,906
369,670 shares
 — 30 Sep 2025
LPL Financial LLC
13F
Company
13F
1.8%
$2,590,869
285,653 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
53
Shares
5,930,184
Rows available
53
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
54
Q4 2025 holders
53
Holder diff
-1
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .